Envoy Medical, Inc.
COCH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -28.8% | 33.3% | -23.5% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $1 |
| Gross Profit | -$1 | -$0 | -$0 | -$0 |
| % Margin | -229.8% | -149.7% | -110.1% | -148.1% |
| R&D Expenses | $10 | $9 | $5 | $4 |
| G&A Expenses | $7 | $7 | $3 | $2 |
| SG&A Expenses | $9 | $9 | $3 | $2 |
| Sales & Mktg Exp. | $2 | $2 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $18 | $8 | $6 |
| Operating Income | -$19 | -$18 | -$9 | -$7 |
| % Margin | -8,558.2% | -5,809.8% | -3,673.4% | -2,216.5% |
| Other Income/Exp. Net | -$2 | -$12 | -$7 | -$2 |
| Pre-Tax Income | -$21 | -$30 | -$16 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21 | -$30 | -$16 | -$9 |
| % Margin | -9,242.2% | -9,469% | -6,718.6% | -2,798.4% |
| EPS | -1.49 | -2.54 | -1.57 | -1.05 |
| % Growth | 41.3% | -61.8% | -49.5% | – |
| EPS Diluted | -1.49 | -2.54 | -1.57 | -1.05 |
| Weighted Avg Shares Out | 19 | 13 | 10 | 10 |
| Weighted Avg Shares Out Dil | 19 | 13 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$20 | -$30 | -$9 | -$7 |
| % Margin | -8,802.7% | -9,426.9% | -3,641.8% | -2,193.5% |